Unlock instant, AI-driven research and patent intelligence for your innovation.

Montelukast sodium chewable tablet and preparation method thereof

A technology of montelukast sodium and chewable tablets, which is applied in the field of medicine, can solve the problems of safety risks, ethanol is volatile and explosive, and unfavorable to industrialization, so as to reduce the cost of medication, increase the dissolution rate, and avoid potential safety hazards.

Active Publication Date: 2020-04-14
SINOPHARM GRP ZHIJUN SHENZHEN PINGSHAN PHARMA CO LTD +1
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The production process of the powder direct compression method is simple and the production cycle is short, but the powder fluidity is poor, the size is small, it is not easy to mix, and it is more likely to have stratification problems during tablet compression, which is not conducive to industrialization
At present, montelukast sodium chewable tablets are mostly produced by wet granulation process, and some wet granulation processes use ethanol as the binder solution. Ethanol is easy to volatilize and explode during the drying process, posing safety risks

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Montelukast sodium chewable tablet and preparation method thereof
  • Montelukast sodium chewable tablet and preparation method thereof
  • Montelukast sodium chewable tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0036] The preparation method of the montelukast sodium chewable tablet of one embodiment, the method comprises the following steps:

[0037] S1: Mixing montelukast sodium, the first binder and water to obtain a montelukast sodium solution.

[0038] In the present invention, montelukast sodium is [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinoline) vinyl]phenyl-3-[ The Chinese product name of 2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfur]methyl]cyclopropane sodium acetate, the English product name is Montelukast sodium, and the CAS number is 151767-02-1. Molecular formula is C 35 h 35 ClNNaO 3 S, the structural formula is:

[0039]

[0040] In one embodiment, the concentration of montelukast sodium in the montelukast sodium solution is 40 μg / mg-70 μg / mg. If the concentration of the montelukast sodium solution is too low, it will be unfavorable for subsequent granulation due to excessive water content; if the concentration is too high, the uniformity of the active ingredients ...

Embodiment 1

[0076] The preparation process of the montelukast sodium chewable tablet of the present embodiment is as follows:

[0077] (1) Mix 5.2 mg of montelukast sodium, 5.2 mg of hydroxypropyl cellulose and 93.6 mg of water in the dark at 25°C to obtain 104.0 mg of montelukast sodium solution;

[0078] (2) Mannitol 194.8 mg, microcrystalline cellulose 60 mg, hydroxypropyl cellulose 9 mg, croscarmellose sodium 9 mg, aspartame 3 mg, cherry essence 3 mg and iron oxide red 3 mg were wet granulated Mix evenly in the machine, and the condition parameters of the wet granulator are stirring 240rpm, cutting 1800rpm, and time 5min to obtain 281.8mg of premixed excipients; add the montelukast sodium solution in step (1) to the wet granulation within 2h of preparation Mix with the above-mentioned premixed auxiliary materials in the machine, and carry out wet granulation under the conditions of stirring 240 rpm and cutting 1800 rpm, and the granulation time is 5 minutes to obtain wet granules;

...

Embodiment 2

[0082]The preparation process of the montelukast sodium chewable tablet of this example is roughly the same as that of Example 1, the difference is that the step (1) of this example is: at 25°C in the dark, 5.2mg of montelukast sodium, 5.2 mg of povidone was mixed with 75.8 mg of water to obtain a solution of 86.2 mg of montelukast sodium.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Hardnessaaaaaaaaaa
Login to View More

Abstract

The invention relates to montelukast sodium chewable tablet and a preparation method thereof. The method includes the steps of: mixing montelukast sodium, a first adhesive and water to obtain a montelukast sodium solution; mixing the montelukast sodium solution with a pharmaceutic adjuvant, and then performing granulation to obtain wet granules; drying the wet particles to obtain dried particles;and molding the dried granules to obtain the montelukast sodium chewable tablet. The method provided by the invention avoids the potential safety hazards in the production process, is easy for industrialization, also the product has uniform effective components, high dissolution rate, good stability and no organic residue, and is beneficial to medication for children.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a montelukast sodium chewable tablet and a preparation method thereof. Background technique [0002] Montelukast sodium is an anti-leukotriene anti-asthma drug originally developed by Merck Sharp & Dohme Ltd in the United States. It is suitable for the prevention and long-term treatment of asthma in adults and children. It is currently the best-selling asthma treatment drug in the world. [0003] The current dosage forms of montelukast sodium include film-coated tablets, chewable tablets, orally disintegrating tablets, and granules. Due to the small size of the finished product, the requirements for content uniformity are high, and industrialization is difficult. The traditional preparation process is mainly based on powder direct compression and wet granulation. The production process of the powder direct compression method is simple and the production cycle is short, but the powder flu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/20A61K47/38A61K47/26A61K47/02A61K47/18A61K31/47A61P11/06
CPCA61K9/0056A61K9/2009A61K9/2013A61K9/2018A61K9/2054A61K9/2095A61K31/47A61P11/06
Inventor 韦斌赖振洪泮卫红陈振阳郑佳媛强皎黄艳曾环想叶家宏
Owner SINOPHARM GRP ZHIJUN SHENZHEN PINGSHAN PHARMA CO LTD